Top Markets
Coin of the day
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Rang in Aktien #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Aktienkurs
$0.17616661
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$73.48M
Veränderung (1 Tag)
0.18%
Veränderung (1 Jahr)
-37.76%
Land
TW
Handel Mercury Biopharmaceutical Corporation (6932)

Kategorie

Kursverlauf für Mercury Biopharmaceutical Corporation (6932)
Höchster Schlusskurs: $0.19 am 2026-08-01

Niedrigster Schlusskurs: $0.35 am 2022-12-01
Kursverlauf der Aktie von Mercury Biopharmaceutical Corporation von 2022 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -18.88%
2025 -28.11%
2024 -33.04%
2023 75.06%
2022 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN